| 摘要 |
The present invention is directed to novel peptides and compositions capable of modulating apoptosis in cells, and to methods of modulating apoptosis employing the novel peptides and compositions of the invention. In one aspect, the invention is directed to novel homologs of bcl-2 designated CDN-1, CDN-2, and CDN-3, and fragments, variants, homologs and derivatives thereof, which are capable of modulating apoptosis.
|
